UBS Group’s Sanofi SNY Stock Holding History

UBS Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-51,400	Closed	-$2.43M	–	11107
2025 Q3	$2.43M	Buy	+51,400	New	+$2.48M	﹤0.01%	4780
2024 Q3	–	Sell	-30,000	Closed	-$1.46M	–	10026
2024 Q2	$1.46M	Buy	+30,000	New	+$1.45M	﹤0.01%	4066
2023 Q4	–	Sell	-58,600	Closed	-$3.14M	–	9841
2023 Q3	$3.14M	Buy	+58,600	New	+$3.12M	﹤0.01%	3015
2022 Q4	–	Sell	-86,900	Closed	-$3.3M	–	11111
2022 Q3	$3.3M	Buy	+86,900	New	+$3.87M	﹤0.01%	2720
2022 Q1	–	Sell	-118,800	Closed	-$5.95M	–	10846
2021 Q4	$5.95M	Buy	118,800 +28,800	+32%	+$1.42M	﹤0.01%	2637
2021 Q3	$4.34M	Buy	+90,000	New	+$4.58M	﹤0.01%	2822
2018 Q3	–	Sell	-20,000	Closed	-$800K	–	8247
2018 Q2	$800K	Buy	+20,000	New	+$787K	﹤0.01%	3961
2015 Q3	–	Sell	-1,200	Closed	-$59K	–	8612
2015 Q2	$59K	Buy	1,200 +800	+200%	+$40.5K	﹤0.01%	5855
2015 Q1	$20K	Sell	400 -1,800	-82%	-$86.1K	﹤0.01%	6989
2014 Q4	$100K	Buy	+2,200	New	+$107K	﹤0.01%	5706

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS Group's SNY Position: Q1 2026 in Review

UBS Group reduced its Sanofi (SNY) stake by 19% in Q1 2026, selling an estimated $11.1M and leaving 983,846 shares worth $47.4M. The position accounts for 0.01% of the portfolio, ranked #1701.

UBS Group first reported a position in SNY in Q4 2014 and has held it in 46 quarters since. The position peaked at $89M in Q1 2015. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

UBS Group held 983,846 shares of Sanofi worth $47.4M as of Q1 2026.
UBS Group sold 238,157 Sanofi shares in Q1 2026, an estimated $11.1M.
Sanofi made up 0.01% of UBS Group's portfolio in Q1 2026, its #1701 holding.
UBS Group first reported a position in Sanofi in Q4 2014 and has held it in 46 quarters since.
UBS Group's Sanofi position peaked at $89M in Q1 2015.
738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.